HR Execs on the Move

DKKD Staffing

www.dkkdstaffing.com

 
DKKD Staffing is located in Westlake Village, California, offering Direct Hire, Contract and Payroll Services across the US. DKKD Staffing specializes in Management and Technology Staffing & Recruiting, and also has a strong network for Finance, Accounting and Administrative needs. We screen for technical skills, as well as the right chemistry matches. No client too large or too small. DKKD Staffing is owned and operated by Diane ``Di`` Krehbiel who also manages the Group site on Linked In called Diane Krehbiel Executive and Technology Recruiting.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million
  • www.dkkdstaffing.com
  • 3390 Auto Mall Drive, Suite 200
    Westlake Village, CA USA 91362
  • Phone: 818.206.6383
  • Fax: 800.761.5024

Executives

Name Title Contact Details

Jobs

CTO (Healthcare/Hospital)

DKKD Staffing Los Angeles,CA
JOB DESCRIPTION: Under the direction of the Chief Information Officer, the Chief Technology Officer will provide direct strategic support, technology vision and lead the development and implementation of the system wide information technology (IT) program based on the objectives, core competencies and market characteristics of the Client. This position is ...

Similar Companies

Lavely and Singer Professional Corporation

Lavely & Singer Professional Corporation is one of the leading companies in Business Services industry. Lavely & Singer Professional Corporation is based in Los Angeles, CA. You can find more information on Lavely & Singer Professional Corporation at www.lavelysinger.com

Lennon Smith Souleret Engrg

Lennon Smith Souleret Engrg is a Coraopolis, PA-based company in the Business Services sector.

HW Media

Scenic Landscaping

Scenic Landscaping LLC is a Haskell, NJ-based company in the Business Services sector.

Cellerant

Cellerant Therapeutics is a clinical stage biotechnology company focused on developing human stem cell and antibody therapies for oncology applications and blood-related disorders. Cellerant`s programs include: CLT-008, an off-the-shelf cellular immunotherapy, under evaluation in a multicenter, open-label, randomized, controlled Phase 2 clinical trial in patients with de novo AML; CSC030-ADC, a preclinical monoclonal antibody drug conjugate that selectively targets and kills leukemic stem and blast cells responsible for initiating and maintaining disease; and CSC012, a preclinical monoclonal antibody targeting leukemic and pre-leukemic stem cells for acute leukemias and myelodysplastic syndromes. The Company is also developing next generation CAR product candidates leveraging its proprietary immunocellular therapy and antibody discovery and development platform.